Affiliate disclosure: This article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. This does not influence our assessment of the evidence below.
Evidence rating: Moderate — citrulline and maritime pine bark both carry randomized human data, though the effect sizes are smaller than the marketing implies
What The 20 Claims To Be
The 20 sells supplements on a stated “80/20” philosophy — use the 20% of ingredients that actually do something and drop the filler. FLOW, their nitric oxide product, is the clearest expression of that idea: four whole-food-derived inputs, no proprietary kitchen sink.
The pitch is nitric oxide. Your blood vessels produce NO to relax and widen; more of it is supposed to mean better circulation, lower blood pressure, better pumps in the gym, and better everything downstream of blood flow. It is a real physiological pathway, not marketing fiction — the question is whether these particular inputs move it meaningfully.
What’s Actually In It
FLOW’s stated composition is short:
- L-citrulline from fermented organic watermelon rind
- Fermented organic spinach
- Organic acerola cherry
- Pine bark extract (Pinus pinaster)
The logic is coherent. Citrulline is the amino acid your kidneys convert to arginine, which is the direct substrate for nitric oxide synthase — and dietary citrulline raises plasma arginine more reliably than supplemental arginine does. Spinach contributes dietary nitrate, which the body reduces to nitrite and then to nitric oxide through a separate, oxygen-independent pathway. Acerola is a vitamin C source, and ascorbate helps stabilize nitric oxide against oxidative breakdown. Pine bark supplies procyanidins studied for endothelial effects.
What is missing is the number that matters most: how many milligrams of citrulline per serving. Watermelon rind is a legitimate but dilute source, and the trials below used gram-scale doses.
What The Research Shows
According to PubMed, the citrulline literature is substantial but the results are more modest and more mixed than a sales page would suggest.
Pooled across trials, the blood pressure effect is real but small. A 2025 systematic review and meta-analysis of 15 randomized controlled trials (24 datasets, 415 participants) found L-citrulline supplementation and watermelon intake significantly lowered systolic blood pressure by 4.02 mmHg and diastolic by 2.54 mmHg in middle-aged and older adults. Notably, the subgroup receiving citrulline combined with arginine did far better — a 10.44 mmHg systolic drop — than citrulline or watermelon alone. DOI
A crossover trial found meaningful vascular changes. Fourteen obese middle-aged adults with prehypertension or stage 1 hypertension took 6 g daily of watermelon extract for six weeks in a randomized crossover against placebo. Brachial systolic pressure fell 15.1 mmHg, ankle systolic 11.5 mmHg, and carotid augmentation index — a marker of arterial wave reflection — dropped 8.8%, all significant versus placebo. DOI
But a larger parallel-group trial did not beat placebo. This is the finding worth sitting with. Forty prehypertensive and hypertensive volunteers took 6 g of watermelon extract or placebo daily for six weeks. The extract group’s systolic pressure fell from 137.8 to 126.0 mmHg and diastolic from 79.2 to 72.3 — impressive on its own. But the authors report no significant difference compared to the placebo group. Within-group improvement without between-group separation is exactly the pattern that inflates supplement claims. DOI
Maritime pine bark has independent endothelial evidence. In a double-blind placebo-controlled multicenter trial of 77 people with type 2 diabetes, 100 mg daily of French maritime pine bark extract for 12 weeks significantly lowered plasma glucose against placebo and significantly decreased endothelin-1, a potent vasoconstrictor, while raising prostacyclin. Plasma nitric oxide rose in both groups, but the difference between them did not reach significance. DOI
The Honest Verdict
What holds up: Citrulline is one of the few genuinely well-studied ingredients in the sports and circulation category, with a meta-analysis behind it rather than a single flattering trial. The mechanism is established biochemistry. Spinach nitrate and vitamin C are sensible co-inputs on the same pathway, and maritime pine bark has its own randomized endothelial data. The formula is short and the ingredients are named — that alone puts it ahead of most competitors.
What doesn’t: The magnitude. Four mmHg systolic is a real but modest shift, not a transformation. The parallel-group watermelon trial failing to separate from placebo is a genuine mark against the strongest version of the claim. The meta-analysis subgroup finding suggests citrulline works best paired with arginine, which FLOW does not include. And without a disclosed citrulline dose, there is no way to know whether a serving approaches the 6 g used in these studies or falls well short of it — that is the single most important question to ask before buying.
Who this makes sense for: Adults interested in circulatory support who want a clean, short-label option and have realistic expectations about scale. It is also a reasonable pre-workout alternative for people who dislike stimulants.
Who should skip it: Anyone on blood pressure medication, nitrates, or PDE5 inhibitors should talk to their doctor first — additive vasodilation is a real interaction, not a theoretical one. Anyone expecting a supplement to replace antihypertensive treatment should skip it outright, and anyone unwilling to email the company for the per-serving citrulline dose is buying blind.
Check current pricing and availability
View The 20 on the official site
This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Talk to your physician before starting any supplement, especially if you have a diagnosed condition or take medication.
Research cited via PubMed: